Fette sets up Goa tablet testing unit

By Gareth Macdonald

- Last updated on GMT

Related tags: Manufacturing

German machine tool maker Fette Compacting has set up a tablet compression and flowability testing centre in Goa, India.

The unit, which cost €600,000 to set up according to the Machinist.in​ website, houses laboratories for small-scale compression trials, sample production, materials analysis as well as capabilities for proof of concept tablet studies.

Fette’s Indian subsidiary, Fette Compacting Machinery India (FCI), will manage operations which will also include a training centre at which pharma customers can gain hands on experience of the latest tabletting platforms.

FCI MD Venkata Subramanian told India’s Business Standard that: “The centre is basically to support our clients in India, both the domestic and multi national pharma companies which have manufacturing facilities in India​.”

Subramanian also predicted that the Goa unit will generate business for the wider Fette group, particularly in terms of technology sales.

He told The Hindu newspaper that: “FCI will enable the manufacturers to fit into the production line by installing the tool and pressing machines, which are either being imported from Germany or sourced locally​.”

FCI has installed 80 tabletting machines in pharmaceutical production facilities across Indian and claims both local majors like Lupin and Dr Reddy’s and global players like GSK, Sanofi Aventis and Ranbaxy as customers.

With the new centre up and running FCI is aiming to sell between 35 and 40 more this year and generate revenues of €14m.

The Goa competence centre is the fourth that Fette has established outside Germany and is the third in Asia, behind the unit it recently opened in Singapore and the facility it set up in Nanjing, China in 2004.

Related news

Show more

Related products

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars